HemaSphere (Aug 2023)

P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS

Rebecca Bamford,
Shayda Maleki-Toyserkani,
Will Taverner,
Josh Freedman,
Matt Hayman,
Manoj Saini,
Sarah Gooding,
Karthik Ramasamy,
Kerry Fisher,
Margaret Duffy

Affiliations

Rebecca Bamford: 1 Theolytics, United Kingdom
Shayda Maleki-Toyserkani: 1 Theolytics, United Kingdom
Will Taverner: 1 Theolytics, United Kingdom
Josh Freedman: 1 Theolytics, United Kingdom
Matt Hayman: 1 Theolytics, United Kingdom
Manoj Saini: 1 Theolytics, United Kingdom
Sarah Gooding: 2 University of Oxford, United Kingdom
Karthik Ramasamy: 2 University of Oxford, United Kingdom
Kerry Fisher: 1 Theolytics, United Kingdom
Margaret Duffy: 1 Theolytics, United Kingdom

DOI: https://doi.org/10.1097/01.HS9.0000972336.33493.9c
Journal volume & issue: Vol. 7
p. e334939c

Abstract

No abstracts available.

Published in HemaSphere

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: https://onlinelibrary.wiley.com/journal/25729241

About the journal